← Back

DOD Biotech Public Company Limited

DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it offers advisory, trading, and supplementary services; and research and development, design, FDA and HALAL registration, and consulting services. DOD Biotech Public Company Limited was incorporated in 2011 and is based in Mueang Samut Sakhon, Thailand.

Price · split & dividend adjusted
News & notes moving DOD.BK
DOD.BK▲6

DOD recovers 63 million baht in deposits to bolster liquidity amid geopolitical risks

DOD Biotech Public Company Limited, or DOD, has negotiated the return of deposits and advance payments from various investment projects totaling more than 63 million baht to manage risks from the Middle East conflict and maintain financial liquidity. Ms. Suwarin Konthong, Chief Financial Officer, said the board and management reviewed investment plans for expanding production lines and acquiring assets that had been decided before the war began, and adopted proactive measures to negotiate partial refunds under contract terms with external counterparties. The company also strengthened internal controls by capping trial payment approvals at no more than 1 million baht per transaction, requiring recovery within 7 days, and reporting progress to the board every 30 days. For the second quarter of 2026, the company posted sales revenue of 122 million baht and profit attributable to the parent of 0.95 million baht amid a slowing economy.
DOD.BK ▲
thunhoon.com·1dRead more ▾
DOD.BK

NAM moves forward with second-half portfolio expansion

NAM announced its second-half strategy to expand its portfolio across the entire value chain, from upstream to downstream, while building its brand to increase margins and create brand loyalty. The company is also expanding into international markets through subsidiaries in Malaysia and Italy, and setting up an SKD parts assembly base in Indonesia with a local partner. Meanwhile, EURO reported first-half revenue from sales and services of 749 million baht, up 12.6 percent, and net profit of 87 million baht, up 26.9 percent from the same period last year. The company targets full-year revenue growth of 10 to 15 percent and plans to open the first phase of Euro Creations T3 at the end of this year. DOD announced a revised investment strategy by negotiating to recover deposits and advance payments for some projects in order to manage risk and maintain the highest level of financial liquidity and security.
EURO.BK ▲NAM.BK ▲DOD.BK
Share2Trade·2dRead more ▾
DOD.BK2

SEC approves extension for DOD to submit revised Q1 2026 financials to 14 August 2026

The Securities and Exchange Commission has approved DOD Biotech Public Company Limited's request to extend the deadline for submitting its revised first quarter 2026 financial statements to 14 August 2026, from the original deadline of 27 July 2026. The company sought the extension due to a large volume of supporting documents and transaction details, requiring the auditor additional time for thorough review to ensure the financial statements are fully accurate and complete. Previously, the SEC issued a letter dated 25 June 2026 instructing the company to amend the financial statements regarding prepayments and advance payments, and the company submitted some related documents on 10 July 2026, before receiving the extension approval letter number 154/2026 dated 17 July 2026.
DOD.BK
InfoQuest·38dRead more ▾
© 2026 MarketDXAsset